Skip to main content Back to Top

Continuing the Dialogue: Clinical Conversations on Neuromuscular Blockade and Reversal Strategies


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this interprofessional conversation, expert faculty discuss evidence supporting quantitative neuromuscular monitoring (NMM) versus qualitative NMM, which quantitative monitors are available in the U.S., and evidence/guidelines supporting monitoring preferences. NMM and complete neuromuscular blockade (NMB) reversal in patients at high risk for residual NMB (rNMB), including elderly and obese patients, will also be discussed.

To learn more about neuromuscular blockade and reversal visit


Rachel WolfeRachel C. Wolfe, Pharm.D., M.H.A., BCCCP, is Clinical Pharmacy Specialist of Perioperative and Surgical Critical Care at Barnes-Jewish Hospital and Washington University Medical Center in St. Louis, Missouri. She is also Adjunct Clinical Instructor for the Barnes-Jewish Hospital Goldfarb School of Nursing and St. Louis College of Pharmacy. Dr. Wolfe earned her Doctor of Pharmacy degree from St. Louis College of Pharmacy and Master of Health Administration degree from Webster University, also in St. Louis. She completed her residency training at University of Kentucky HealthCare, and she is board certified in critical care.

Relevant Financial Relationship Disclosure with an Ineligible Company

  • Consultant and Speakers Bureau, Merck

All of the relevant financial relationships have been mitigated.

Deborah WagonerDeborah Wagner, Pharm.D., FASHP, is Clinical Professor at the University of Michigan College of Pharmacy and Clinical Professor of Anesthesiology at Michigan Medicine in Ann Arbor. Dr. Wagner earned her Doctor of Pharmacy degree from the University Of Michigan College Of Pharmacy. She is a fellow of ASHP.

Relevant Financial Relationship Disclosure with an Ineligible Company

  • Advisory Board, Merck and Fresenius Kabi

All of the relevant financial relationships have been mitigated.

Glenn MurphyGlenn Murphy, M.D., is an anesthesiologist at Advocate Illinois Masonic Medical Center in Chicago, Illinois. Previously, he was the Jeffery S. Vender Chair of Anesthesiology Research and Education and Director of Cardiac Anesthesia and Clinical Research at NorthShore University HealthSystem, a hospital affiliated with the University of Chicago Pritzker School of Medicine. He received his Doctor of Medicine from Hahnemann University and completed an anesthesiology residency at Northwestern University Medical School in Chicago, Illinois. He is Diplomate, American Board of Anesthesiology and Board Certified in intraoperative transesophageal echocardiography.

Relevant Financial Relationship Disclosure with an Ineligible Company

  • Speakers Bureau and Advisory Board, Merck

All of the relevant financial relationships have been mitigated.

All others in control of the content of this activity do not have a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company.

This podcast is provided by ASHP and supported by Merck.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP 2020 Summer Sessions

2020 ASHP Summer Sessions

New to Summer Sessions?
Welcome to our new format!
Start Here
Link the whole card

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management
Learn More
Link the whole card